Valproic Acid, a Molecular Lead to Multiple Regulatory Pathways Cited by

Fol. Biol. 2007, 53, 37-49

https://doi.org/10.14712/fb2007053020037

Valproic Acid, a Molecular Lead to Multiple Regulatory Pathways

M. Kostrouchová¹, Z. Kostrouch¹, Marta Kostrouchová²

¹Laboratory of Molecular Pathology, Institute of Inherited Metabolic Disorders of the 1st Faculty of Medicine, Charles University, Prague, Czech Republic
²Laboratory of Molecular Biology and Genetics, Institute of Inherited Metabolic Disorders of the 1st Faculty of Medicine, Charles University, Prague, Czech Republic

Received February 2007
Accepted March 2007

Crossref Cited-by Linking

Kim Jeongah, Park Si-Hyung, Sun Woong: The Differential Developmental Neurotoxicity of Valproic Acid on Anterior and Posterior Neural Induction of Human Pluripotent Stem Cells. Int J Stem Cells 2025, 18, 49. <https://doi.org/10.15283/ijsc24066>
Cergel Eda, Tuzuner Burcin Alev, Turkyilmaz Ismet Burcu, Oktay Sehkar, Magaji Umar Faruk, Sacan Ozlem, Yanardag Refiye, Yarat Aysen: Reversal of Valproate\u2010Induced Major Salivary Gland Changes By Moringa Oleifera Extract in Rats. Chemistry & Biodiversity 2024, 21. <https://doi.org/10.1002/cbdv.202301959>
Elik Gülsüm, Oktay Sehkar, Turkyilmaz Ismet Burcu, Alev-Tuzuner Burcin, Magaji Umar Faruk, Sacan Ozlem, Yanardag Refiye, Yarat Aysen: Dermatoprotective effect of Moringa oleifera leaf extract on sodium valproate-induced skin damage in rats. Drug and Chemical Toxicology 2024, 47, 1257. <https://doi.org/10.1080/01480545.2024.2369586>
Long Jun, Chang Li, Shen Yan, Gao Wen-Hui, Wu Yue-Nv, Dou Han-Bo, Huang Meng-Meng, Wang Ying, Fang Wei-Yue, Shan Jie-Hui, Wang Yue-Ying, Zhu Jiang, Chen Zhu, Hu Jiong: Valproic Acid Ameliorates Graft-versus-Host Disease by Downregulating Th1 and Th17 Cells. The Journal of Immunology 2015, 195, 1849. <https://doi.org/10.4049/jimmunol.1500578>
Bitman Michal, Vrzal Radim, Dvorak Zdenek, Pavek Petr: Valproate activates ERK signaling pathway in primary human hepatocytes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2014, 158, 039. <https://doi.org/10.5507/bp.2012.038>
Chiu Chi-Tso, Wang Zhifei, Hunsberger Joshua G., Chuang De-Maw: Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder. Pharmacological Reviews 2013, 65, 105. <https://doi.org/10.1124/pr.111.005512>
Van Nifterik Krista A., Van den Berg Jaap, Slotman Ben J., Lafleur M. Vincent M., Sminia Peter, Stalpers Lukas J. A.: Valproic acid sensitizes human glioma cells for temozolomide and \u03b3-radiation. J Neurooncol 2012, 107, 61. <https://doi.org/10.1007/s11060-011-0725-z>
Rossetti Franco, de Araujo Furtado Marcio, Pak Thomas, Bailey Keenan, Shields Mallory, Chanda Soma, Addis Michael, Robertson Benjamin D., Moffett Mark, Lumley Lucille A., Yourick Debra L.: Combined diazepam and HDAC inhibitor treatment protects against seizures and neuronal damage caused by soman exposure. NeuroToxicology 2012, 33, 500. <https://doi.org/10.1016/j.neuro.2012.02.010>
Cowden John, Padnos Beth, Hunter Deborah, MacPhail Robert, Jensen Karl, Padilla Stephanie: Developmental exposure to valproate and ethanol alters locomotor activity and retino-tectal projection area in zebrafish embryos. Reproductive Toxicology 2012, 33, 165. <https://doi.org/10.1016/j.reprotox.2011.11.111>
Dell'Aversana Carmela, Lepore Ilaria, Altucci Lucia: HDAC modulation and cell death in the clinic. Experimental Cell Research 2012, 318, 1229. <https://doi.org/10.1016/j.yexcr.2012.01.025>
Wittenburg Luke A., Bisson Liam, Rose Barbara J., Korch Christopher, Thamm Douglas H.: The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin. Cancer Chemother Pharmacol 2011, 67, 83. <https://doi.org/10.1007/s00280-010-1287-z>
Khan Sabbir, Ahmad Tauseef, Parekh Chintan Vishnubhai, Trivedi Priyanka Pushkarbhai, Kushwaha Sapana, Jena Gopabandhu: Investigation on sodium valproate induced germ cell damage, oxidative stress and genotoxicity in male Swiss mice. Reproductive Toxicology 2011, 32, 385. <https://doi.org/10.1016/j.reprotox.2011.09.007>
Gotfryd Kamil, Hansen Maria, Kawa Anna, Ellerbeck Ursula, Nau Heinz, Berezin Vladimir, Bock Elisabeth, Walmod Peter S.: The Teratogenic Potencies of Valproic Acid Derivatives and Their Effects on Biological End\u2010points are Related to Changes in Histone Deacetylase and Erk1/2 Activities. Basic Clin Pharma Tox 2011, 109, 164. <https://doi.org/10.1111/j.1742-7843.2011.00702.x>
Wu Jason Boyang, Shih Jean C.: Valproic Acid Induces Monoamine Oxidase A via Akt/Forkhead Box O1 Activation. Molecular Pharmacology 2011, 80, 714. <https://doi.org/10.1124/mol.111.072744>
Go Hyo Sang, Seo Jung Eun, Kim Ki Chan, Han So Min, Kim Pitna, Kang Young Sun, Han Seol Heui, Shin Chan Young, Ko Kwang Ho: Valproic acid inhibits neural progenitor cell death by activation of NF-\u03baB signaling pathway and up-regulation of Bcl-XL. J Biomed Sci 2011, 18. <https://doi.org/10.1186/1423-0127-18-48>
Haerian Batoul Sadat, Lim Kheng Seang, Tan Chong Tin, Raymond Azman Ali, Mohamed Zahurin: Association of ABCB1 Gene Polymorphisms and Their Haplotypes with Response to Antiepileptic Drugs: a Systematic Review and Meta-Analysis. Pharmacogenomics 2011, 12, 713. <https://doi.org/10.2217/pgs.10.212>
Jentink Janneke, Bakker Marian K., Nijenhuis Cynthia M., Wilffert Bob, de Jong-van den Berg Lolkje T.W.: Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?. Pharmacoepidem. Drug Safe. 2010, 19, 803. <https://doi.org/10.1002/pds.1975>
Nuutinen Tapio, Suuronen Tiina, Kauppinen Anu, Salminen Antero: Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease. Neuroscience Letters 2010, 475, 64. <https://doi.org/10.1016/j.neulet.2010.03.041>
Umka J., Mustafa S., ElBeltagy M., Thorpe A., Latif L., Bennett G., Wigmore P.M.: Valproic acid reduces spatial working memory and cell proliferation in the hippocampus. Neuroscience 2010, 166, 15. <https://doi.org/10.1016/j.neuroscience.2009.11.073>
Zhang Z.Y., Zhang Z., Schluesener H.J.: MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis. Neuroscience 2010, 169, 370. <https://doi.org/10.1016/j.neuroscience.2010.04.074>
ADAB NAGHME, O'DONOGHUE MICHAEL F: ANTI-EPILEPTIC DRUGS AND BRAIN AND BEHAVIOURAL DEVELOPMENT IN ANIMAL MODELS AND HUMANS. Fet. Matern. Med. Rev. 2010, 21, 283. <https://doi.org/10.1017/S0965539510000100>
Gotfryd Kamil, Skladchikova Galina, Lepekhin Eugene A, Berezin Vladimir, Bock Elisabeth, Walmod Peter S: Cell type-specific anti-cancer properties of valproic acid: independent effects on HDAC activity and Erk1/2 phosphorylation. BMC Cancer 2010, 10. <https://doi.org/10.1186/1471-2407-10-383>
Erlich Rafael B., Rickwood Danny, Coman William B., Saunders Nicholas A., Guminski Alexander: Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas. Cancer Chemother Pharmacol 2009, 63, 381. <https://doi.org/10.1007/s00280-008-0747-1>
Cournoyer Philippe, Desrosiers Richard R.: Valproic acid enhances protein l-isoaspartyl methyltransferase expression by stimulating extracellular signal-regulated kinase signaling pathway. Neuropharmacology 2009, 56, 839. <https://doi.org/10.1016/j.neuropharm.2009.01.008>
Zádori Dénes, Geisz Andrea, Vámos Enik\u0151, Vécsei László, Klivényi Péter: Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease. Pharmacology Biochemistry and Behavior 2009, 94, 148. <https://doi.org/10.1016/j.pbb.2009.08.001>
Erhart S, Amann A, Haberlandt E, Edlinger G, Schmid A, Filipiak W, Schwarz K, Mochalski P, Rostasy K, Karall D, Scholl-Bürgi S: 3-Heptanone as a potential new marker for valproic acid therapy. J. Breath Res. 2009, 3, 016004. <https://doi.org/10.1088/1752-7155/3/1/016004>
Bouzar Amel Baya, Boxus Mathieu, Defoiche Julien, Berchem Guy, Macallan Derek, Pettengell Ruth, Willis Fenella, Burny Arsène, Lagneaux Laurence, Bron Dominique, Chatelain Bernard, Chatelain Christian, Willems Luc: Valproate synergizes with purine nucleoside analogues to induce apoptosis of B\u2010chronic lymphocytic leukaemia cells. Br J Haematol 2009, 144, 41. <https://doi.org/10.1111/j.1365-2141.2008.07426.x>
Floris Giuseppe, Debiec-Rychter Maria, Sciot Raf, Stefan Cristiana, Fieuws Steffen, Machiels Kathleen, Atadja Peter, Wozniak Agnieszka, Faa Gavino, Scho\u0308ffski Patrick: High Efficacy of Panobinostat Towards Human Gastrointestinal Stromal Tumors in a Xenograft Mouse Model. Clinical Cancer Research 2009, 15, 4066. <https://doi.org/10.1158/1078-0432.CCR-08-2588>
Smith Jacqueline, Whitehall John: Sodium Valproate and the Fetus: A Case Study and Review of the Literature. Neonatal Network 2009, 28, 363. <https://doi.org/10.1891/0730-0832.28.6.363>
Fischer Wiebke, Praetor Katrin, Metzner Linda, Neubert Reinhard H.H., Brandsch Matthias: Transport of valproate at intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells: Mechanism and substrate specificity. European Journal of Pharmaceutics and Biopharmaceutics 2008, 70, 486. <https://doi.org/10.1016/j.ejpb.2008.05.022>
Hoffmann Katrin, Czapp Marion, Löscher Wolfgang: Increase in antiepileptic efficacy during prolonged treatment with valproic acid: Role of inhibition of histone deacetylases?. Epilepsy Research 2008, 81, 107. <https://doi.org/10.1016/j.eplepsyres.2008.04.019>
Lamarre Mélanie, Desrosiers Richard R.: Up-regulation of protein l-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and \u03b2-catenin stabilization. Neuropharmacology 2008, 55, 669. <https://doi.org/10.1016/j.neuropharm.2008.05.033>
Krogenæs A.K., Taubøll E., Stien A., Oskam I.C., Lyche J.L., Dahl E., Thomassen R.F., Sweeney T., Ropstad E.: Valproate affects reproductive endocrine function, testis diameter and some semen variables in non-epileptic adolescent goat bucks. Theriogenology 2008, 70, 15. <https://doi.org/10.1016/j.theriogenology.2008.01.029>
Ikeda Masaaki: Effects of moodstabilizer on the circadian system: possible implication for abnormalities in mood disorders. Folia Pharmacol. Jpn. 2007, 130, 469. <https://doi.org/10.1254/fpj.130.469>